Patents by Inventor Jingrong Xu

Jingrong Xu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulations
    Patent number: 11266649
    Abstract: The disclosure provides, inter alia, pharmaceutical compositions comprising micronized drug particles of adenosine A2A receptor antagonists, and methods of treating cancer using the pharmaceutical compositions.
    Type: Grant
    Filed: February 1, 2019
    Date of Patent: March 8, 2022
    Assignee: Corvus Pharmaceuticals, Inc.
    Inventors: Jingrong Xu, William Jones, Felicia Flicker, Bret Berner
  • PHARMACEUTICAL FORMULATIONS
    Publication number: 20210060020
    Abstract: The disclosure provides, inter alia, pharmaceutical compositions comprising micronized drug particles of adenosine A2A receptor antagonists, and methods of treating cancer using the pharmaceutical compositions.
    Type: Application
    Filed: February 1, 2019
    Publication date: March 4, 2021
    Applicant: Corvus Pharmaceuticals, Inc.
    Inventors: Jingrong Xu, William Jones, Felicia Flicker, Bret Berner
  • PHARMACEUTICAL FORMULATIONS
    Publication number: 20190231783
    Abstract: The disclosure provides, inter alia, compositions, oral formulations, amorphous solid dispersions, extrudates, crystalline nanoparticles, and microprecipitated bulk powders containing adenosine A2A receptor antagonists, and methods of using the compositions, oral formulations, amorphous solid dispersions, extrudates, crystalline nanoparticles, and microprecipitated bulk powder to treat cancer.
    Type: Application
    Filed: February 1, 2019
    Publication date: August 1, 2019
    Inventors: Jingrong Xu, William Jones, Felicia Flicker, Brett Berner